| NDC Number | Brand Name | Generic Name | Manufacturer | Dosage Form | DEA Sch. | Marketing Start Date |
|---|---|---|---|---|---|---|
| 64406-008 | TYSABRI | natalizumab | Biogen Inc. | INJECTION | 2004-11-23 | |
| 64764-107 | ENTYVIO | vedolizumab | Takeda Pharmaceuticals America, Inc. | INJECTION, SOLUTION | 2023-09-27 | |
| 64764-108 | ENTYVIO Pen | vedolizumab | Takeda Pharmaceuticals America, Inc. | INJECTION, SOLUTION | 2023-09-27 | |
| 64764-300 | Entyvio | vedolizumab | Takeda Pharmaceuticals America, Inc. | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 2014-05-20 |
Loading full table content...